Literature DB >> 20532679

Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy.

Sinan Akbayram1, Cihangir Akgun, Murat Doğan, Refah Sayin, Huseyin Caksen, Ahmet Faik Oner.   

Abstract

Four children with vincristine (VCR)-induced neuropathy are being reported. All cases were followed with the diagnosis of acute lymphoblastic leukemia. Two were boys aged between 2 and 13 year. Electromyographic examination consisted of sensoriomotor polyneuropathy with axonal involvement in three patients. In another patient, it consisted of motor axonal polyneuropathy. In all patients, pyridoxine and pyridostigmine were successfully used in the treatment of VCR-induced neuropathy. They recovered completely with this drug combination. Recovering period of symptoms was between 1-2 week.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20532679     DOI: 10.1007/s12098-010-0096-z

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

1.  Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine.

Authors:  Lars Müller; Christof M Kramm; Tobias Tenenbaum; Rüdiger Wessalowski; Ulrich Göbel
Journal:  Pediatr Blood Cancer       Date:  2004-03       Impact factor: 3.167

2.  Treatment of vincristine-induced cranial polyneuropathy.

Authors:  Ozgür Duman; Gülsün Tezcan; Volkan Hazar
Journal:  J Pediatr Hematol Oncol       Date:  2005-04       Impact factor: 1.289

3.  Vincristine induced unilateral ptosis.

Authors:  Skorić Dejan; Bogićević Dragana; Petronić Ivana; Babić Borivoje; Petrović Marko
Journal:  J Pediatr Hematol Oncol       Date:  2009-06       Impact factor: 1.289

4.  Vincristine induced cranial polyneuropathy.

Authors:  Ali Bay; Cahide Yilmaz; Nebi Yilmaz; Ahmet Faik Oner
Journal:  Indian J Pediatr       Date:  2006-06       Impact factor: 1.967

Review 5.  Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Authors:  Allen R Chauvenet; Vandana Shashi; Clifford Selsky; Elaine Morgan; Joanne Kurtzberg; Beverly Bell
Journal:  J Pediatr Hematol Oncol       Date:  2003-04       Impact factor: 1.289

6.  Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.

Authors:  S S Moudgil; J E Riggs
Journal:  Ann Pharmacother       Date:  2000-10       Impact factor: 3.154

Review 7.  Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature.

Authors:  R K Sathiapalan; H El-Solh
Journal:  Pediatr Hematol Oncol       Date:  2001-12       Impact factor: 1.969

8.  Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy.

Authors:  Hamit Ozyurek; Hande Turker; Mehtap Akbalik; Ayse Oytun Bayrak; Hulya Ince; Feride Duru
Journal:  Pediatr Hematol Oncol       Date:  2007-09       Impact factor: 1.969

9.  Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.

Authors:  Amalia Schiavetti; Massimo Frascarelli; Stefania Uccini; Antonio Novelli
Journal:  Pediatr Blood Cancer       Date:  2004-10       Impact factor: 3.167

10.  Disorders of colonic motility in patients with diabetes mellitus.

Authors:  W M Battle; J D Cohen; W J Snape
Journal:  Yale J Biol Med       Date:  1983 Jul-Aug
  10 in total
  4 in total

1.  Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review.

Authors:  Ellen M Lavoie Smith; Clare Kuisell; Grace A Kanzawa-Lee; Celia M Bridges; Paola Alberti; Guido Cavaletti; Rima Saad; Susanna Park
Journal:  Lancet Haematol       Date:  2020-05       Impact factor: 18.959

2.  Bilateral Eyelid Ptosis, Attributed to Vincristine, Treated Successfully with Pyridoxine and Thiamine in a Child with Acute Lymphoblastic Leukemia.

Authors:  Emmanuel Hatzipantelis; Ioannis Kyriakidis; Evangelos Pavlou; Efterpi Pavlidou
Journal:  Toxicol Int       Date:  2015 Jan-Apr

3.  Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review.

Authors:  Marie Lindhard Madsen; Hanne Due; Niels Ejskjær; Paw Jensen; Jakob Madsen; Karen Dybkær
Journal:  Cancer Chemother Pharmacol       Date:  2019-06-18       Impact factor: 3.333

4.  Vincristine-induced vocal cord palsy and successful re-treatment in a patient with diffuse large B cell lymphoma: a case report.

Authors:  Zarka Samoon; Munira Shabbir-Moosajee
Journal:  BMC Res Notes       Date:  2014-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.